Short-chain fatty acids (SCFAs), preferably butyric acid and propionic acid, formed by colonic fermentation of dietary fibre have been associated with a number of health-promoting effects. Butyric acid is the main substrate for the colonocytes and may play an important role in the prevention and treatment of colonic diseases such as ulcerative colitis and colon cancer ([@CIT0001], [@CIT0002]). Butyric acid has also been reported to increase colonic blood flow and oxygen uptake ([@CIT0003]), and to stimulate mucosal proliferation ([@CIT0004], [@CIT0005]). On the other hand, butyric acid may also act as an inhibitor of inflammation in the colon, via the inhibition of NF-κB activation and histone deacetylation ([@CIT0006]). This inhibiting effect of butyric acid has also been seen on systemic inflammation ([@CIT0007]). Another interesting SCFA is propionic acid, which may inhibit the synthesis of cholesterol from acetic acid and lower plasma glucose level, thereby playing a role in modulating lipid and glucose metabolism ([@CIT0008], [@CIT0009]).

The profile of SCFAs in the colon has been shown to rely on the type of dietary fibre, the degree of polymerisation of the dietary fibre, the type of linkages between the carbohydrate monomers, and on solubility and monomeric composition ([@CIT0010]). While pectin (polymers containing high amounts of uronic acids) gives high amounts of acetic acid, guar gum (galactomannan) yields high proportions of propionic acid and β-glucan high amounts of butyric acid ([@CIT0010]--[@CIT0012]). Furthermore, fructan of low molecular weight (fructo-oligosaccharides) gives high amounts of butyric acid, in contrast to high-molecular-weight fructan (inulin) ([@CIT0010]--[@CIT0012]), and inulin with low solubility tends to shift the fermentation site from the caecum to the distal colon in rats ([@CIT0010]). Thus, the physico-chemical properties of the fibre are of great importance for the amount and pattern of SCFAs formed.

Apart from the type of carbohydrate, SCFA formation also depends on the composition of the colonic microbiota. One way to improve the profile of the colonic microbiota is by adding probiotics. In recent years, there has been considerable interest in studying supplementation of probiotics with dietary fibre, as a possible way to optimise SCFA formation and enhance the nutritional effect of dietary fibre. For example, a shift in the formation of SCFAs from the caecum to the distal colon was observed in rats fed pectin with *Lactobacillus* UCC500, and *Bifidobacterium* supplementation (Bb-12) increased the levels of SCFAs throughout the colon of rats fed pectin ([@CIT0013]).

Barley malt, which is traditionally used in the brewing industry, is the product of the germination of barley. During germination, the non-starch polysaccharides (NSPs) in the cell wall of barley, constituting mainly arabinoxylans and β-glucans, are solubilised and partly degraded into smaller molecules ([@CIT0014]). These changes probably make NSPs more sensitive to the bacterial fermentation in the human colon. In a previous study, we have shown that feeding rats with barley malt gave rise to higher levels of propionic and butyric acids than the starting material (whole grain barley), and that supplementation with a probiotic strain, *Lactobacillus rhamnosus* 271 (Lr 271), increased the formation further ([@CIT0015]). Increased levels of theses acids in the circulation system may have metabolic effects and influence inflammatory parameters. Furthermore, barley and germinated barley contain large quantities of glutamine ([@CIT0016], [@CIT0017]), which after butyric acid, is the most important substrate for colonic mucosa. Glutamine is easily degraded by the low pH in the stomach, but some of the glutamine is protected by the dietary fibre during digestion in the stomach ([@CIT0017]), and therefore reaches the colon. This is also a proposed explanation of why germinated barley prolongs remission in subjects with ulcerative colitis ([@CIT0018]). Greater formation of butyric acid may reduce the epithelial utilisation of glutamine, thereby increasing the levels of circulating glutamine affecting the immune function.

The aim of the present study was to evaluate the promising synbiotic effect of dietary fibre and some probiotic strains. For this purpose, barley malt, and *Lactobacillus paracasei* 87002 (Paracasei), *Lactobacillus plantarum* HEAL 9 (HEAL 9) and 19 (HEAL 19) and *Bifidobacterium infantis* CURE 21 (CURE 21) were used. To verify previous effects, Lr 271 was also included in diets given to one group of rats. The rat model used has been shown to correlate well to human experiments ([@CIT0019]). The degree of dietary fibre fermentation, formation of SCFAs in the hindgut, levels of SCFAs and amino acids in the portal blood, and the composition of *Lactobacillus* in caecum were investigated. Paracasei has been shown to have strong antagonistic properties, HEAL 9 and 19 were chosen because of their ability to adhere to human epithelial cells and their capacity to break down tannins and CURE 21 can produce glutamine ([@CIT0020]--[@CIT0022]).

Materials and methods {#S0002}
=====================

Materials {#S0002-S20001}
---------

Malt was obtained free of charge by Carlsberg AB (Falkenberg, Sweden), and milled to a particle size less than 0.5 mm before inclusion in the diets. Five lyophilised probiotics, Paracasei, HEAL 9, HEAL 19, CURE 21 and Lr 271 were obtained from Probi AB (Lund, Sweden).

Diets {#S0002-S20002}
-----

The six diets used in the study contained a basal diet mixture (329 g/kg, dry weight) and were prepared according to Henningsson et al. ([@CIT0023]). Malt was added at a level of 68 g dietary fibre per kg dry feed (corresponding to 481 g malt per kg feed, dry weight basis, dwb), and wheat starch (189.7 g/kg, dwb) was used to adjust the dry matter weight. The starch used makes no contribution to the hindgut formation of SCFAs due to complete digestion in the upper gastrointestinal tract ([@CIT0024]). The malt diet without probiotics is referred to as the control diet, and the other five diets containing one of the five probiotic strains are referred to as test diets. The daily amount of probiotics was 1×10^9^ colony forming units (CFU) for each rat, and was added at feeding time.

Animal study design {#S0002-S20003}
-------------------

Male Wistar rats (*n*=42) obtained from Taconic (Ejby, Denmark) were used in the study. The rats were randomly divided into six groups and housed individually in metabolic cages in a room maintained at 22°C and 60% relative humidity in a 12-h light and night circle. After 1 week of acclimatisation to the environment, the rats (131.5±1.1 g) were allowed to adapt to the diet for 7 days before a 5-day long experimental period. Food intake was restricted to 12 g (dwb) per day, and water was given ad libitum. During the experimental period, faeces and feed residues were collected. Faecal material was freeze-dried and milled before analysis of the content of dietary fibre monomers. At the end of the experiment, the rats were anaesthetised by injecting Hypnorm-Dormicum in sterile water (1:1:2) at a dose of 0.15 ml per 100 g body weight. Portal blood was taken for analysis of SCFAs, amino acids and ammonia. Caecal content and proximal and distal colon content were collected for analysis of SCFAs. Caecal pH and the weight of caecal content and tissue were measured directly. The animal experiment was approved by the Ethics Committee for Animal Studies at Lund University (M 30-09).

Analyses {#S0002-S20004}
--------

### Dietary fibre

The soluble and insoluble dietary fibres in malt were determined with an enzymatic, gravimetric method ([@CIT0025]). The Uppsala Method was used to analyse the monomeric composition of the dietary fibre residues and also dietary fibre in faeces ([@CIT0026]), but without the step involving isolation of the dietary fibre. In this method, the dietary fibre residues are first hydrolysed and filtered. The filtrate is then used to analyse neutral sugars by a gas chromatographic (GC) method, as their alditol acetates, and uronic acids by a spectrophotometric method. The content of Klason lignin in the samples was determined as the residue after filtration and combustion of the sample at 550°C for 1 h.

### SCFAs in caecum, colon and serum

A GC method was applied for the analysis of SCFAs in caecal and colonic contents ([@CIT0027]) and in serum ([@CIT0028]). The caecal and colonic contents were homogenised (IKA^®^-WERKE, Staufen, Germany) and centrifuged with 0.25 M HCl to protonise the SCFAs. SCFAs in serum were enriched by a hollow fibre supported liquid membrane extraction technique. Two-ethylbutyric acid (Sigma Chemical Company) was added in each sample as internal standard. After preparation, the samples were injected into a fused-silica capillary column (DB-FFAP 125-3237; J&W Scientific, Agilent Technologies Inc., Folsom, CA, USA). GC ChemStation software (Agilent Technologies Inc., Wilmington, DE, USA) was used for the evaluation of the results.

### Amino acids in plasma

Amino acids in plasma were quantified as free amino acids with an amino acid analyser (Biochrom 30, Biochrom Ltd, Cambridge, UK) based on ion-exchange chromatography. A precipitation step was used to purify the plasma ([@CIT0029]). The EZChrom Elite software package (Scientific Software Inc., Pleasanton, CA, USA) was used to evaluate the results.

### Caecal microbiota

Viable counts of *Bifidobacterium*, *Lactobacillus* and *Enterobacteriaceae* in caecal samples were performed by anaerobical incubation, as described elsewhere ([@CIT0030]). Colonies of *Bifidobacterium* were randomly selected and verified by microscopy. Four *Lactobacillus* colonies obtained from each cultured sample were randomly picked and re-cultured on Rogosa agar as the quantitatively dominant *lactobacilli* in the caecum of rats. The randomly amplified polymorphic DNA method (RAPD) was used to identify the given probiotic strain from the dominant *Lactobacilli*, followed by agarose gel electrophoresis ([@CIT0031]). The unknown *Lactobacilli* were sent for sequencing to identify them at species level (GATC Biotech, Solna, Sweden).

Statistics {#S0002-S20005}
----------

One rat fed malt +CURE 21 suffered a weight loss (6.4 g) during the experiment and showed very low concentrations of SCFAs both in serum and caecal content. The data from this rat were therefore excluded from the statistical analysis as this animal was considered an outlier.

The caecal pool was calculated as the level of each SCFA obtained in the analysis multiplied by the amount of caecal content, which was extrapolated to the complete intake of dietary fibre (4.08 g). Body weight gain during the experimental period was calculated as g/g feed intake. Bulking capacity was calculated as faecal dry weight in g/g fibre ingested.

The results are presented as means and their standard error means (SEM). Effects of probiotics were evaluated by one-way ANOVA followed by Dunnett\'s procedure, where the test diets were compared (*P*\<0.05) with the control diet. Box-Cox transformation was carried out when data was not normally distributed. Minitab version 14 was used for statistical analysis.

Results {#S0003}
=======

Dietary fibre content, composition and hindgut degradation {#S0003-S20001}
----------------------------------------------------------

The content of dietary fibre polysaccharides in malt was 110 g/kg (dwb), of which only a small part was soluble (7%) ([Table 1](#T0001){ref-type="table"}). The main components of the dietary fibre polysaccharides were xylose (37%), glucose (34%) and arabinose (19%). Considerable amounts of uronic acids (5%), galactose and mannose (5%) were also detected. The amount of Klason lignin was 25 g/kg (dwb).

###### 

Dietary fibre content (g/kg), soluble fraction (% of total dietary fibre) and faecal excretion (% of ingested fibre) in rats fed malt and malt together with Paracasei, HEAL 9, HEAL 19, CURE 21 or Lr 271

                                  Dietary fibre   Faecal excretion of dietary fibre                                             
  ------------------------------- --------------- ----------------------------------- ------ ------ ------ ------ ------ ------ -------
  Rhamnose                        ND              ND                                  --     --     --     --     --     --     --
  Arabinose                       21              11                                  48±2   49±2   51±2   52±2   53±2   53±1   0.263
  Xylose                          41              6                                   68±3   69±2   70±2   71±3   72±2   72±1   0.607
  Mannose                         2               15                                  42±2   37±4   42±2   43±2   43±2   46±2   0.147
  Galactose                       3               25                                  63±4   60±3   64±2   63±3   73±4   67±4   0.159
  Glucose                         38              6                                   86±3   86±4   87±3   87±3   90±3   93±3   0.546
  Uronic acids                    5               16                                  63±1   61±3   68±3   68±3   70±2   70±2   0.041
  Dietary fibre polysaccharides   110             8                                   70±2   70±3   72±2   72±3   74±2   75±2   0.534
  Klason lignin                   25              0                                   --     --     --     --     --     --     --
  Total dietary fibre             135             7                                   --     --     --     --     --     --     --

Results are given as means±SEM, *n*=5 for Malt+Paracasei, *n*=6 for Malt+CURE 21 and *n*=7 for all other groups; ND, not detected at a detection limit of 0.5 g/kg.

Dietary fibre polysaccharides in malt were rather resistant to hindgut degradation in rats and only 30% of the ingested fibre was fermented. Among the dietary fibre components, glucose was most resistant to fermentation, and only 14% was utilised by the hindgut microbiota. The other main components, xylose and arabinose were utilised to 32 and 52%, respectively, by the hindgut microbiota. The minor components were fermented to similar degrees: 37--58%. None of the probiotic strains affected the fermentability of the dietary fibre to any greater extent. The only significance seen was the higher degree of fermentation with malt and Paracasei compared with malt and CURE 21 or Lr 271 when suing another statistical test, that is, student\'s *t*-test, than one-way ANOVA.

Caecal content, tissue weight and pH {#S0003-S20002}
------------------------------------

The rats appeared to be healthy throughout the study and ate most of the food provided during the experimental period (11.2--11.8 g/day), which corresponded to 93--98% of the feed intake ([Table 2](#T0002){ref-type="table"}). All the rats included in the analysis gained weight, and no significances were detected between the groups.

###### 

Feed intake, weight gain, caecal content, caecal tissue weight, caecal pH and bulking capacity in rats fed malt and malt together with Paracasei, HEAL 9, HEAL 19, CURE 21 or Lr 271

                                 Malt±probiotics
  ------------------------------ -----------------
  Feed intake (g/day)            11.2--11.8
  Weight gain (g/g feed)         0.16--0.23
  Caecal content (g)             2.1--2.4
  Caecal tissue (g)              0.5
  Caecal pH                      6.5--6.8
  Bulking capacity (g/g fibre)   1.4--1.5

All feed weights are given on a dry weight basis. Results are given as means±SEM, *n*=6 for malt+CURE 21 and *n*=7 for all other groups.

Caecal content and tissue weight were similar in rats fed different diets (2.2±0.1 and 0.53±0.01 g, respectively). The caecal pH was between 6.5 and 6.9, with no differences between groups. No significant difference was observed in the bulking capacity between groups (1.38--1.49 g/g fibre).

SCFAs in the hindgut {#S0003-S20003}
--------------------

The main SCFA formed in the caecum of all rats was acetic acid (104--131 µmol), followed by butyric acid (22--36 µmol) and propionic acid (16--21 µmol) (data not shown), which corresponded to 67--70%, 14--18%, and 10--12% of the total amount of SCFAs formed, respectively.

The caecal levels of total SCFAs were lower in rats fed malt together with HEAL 9 (*P*\<0.01), HEAL 19 (*P*\<0.01) and Lr 271 (*P*\<0.05) than without these strains, mainly due to a decrease in the levels of acetic acid (*P*\<0.01, 0.01 and 0.05, respectively), but also due to decreased levels of butyric acid (*P*\<0.01 for HEAL 9 and *P*\<0.05 for HEAL 19). The probiotic groups had lower levels of SCFAs in the distal colon than the group fed diets containing no probiotics, although this was not significant ([Table 3](#T0003){ref-type="table"}).

###### 

Levels of SCFAs in the caecum (µmol/g), distal colon (µmol/g) and portal serum (µmol/l) of rats fed malt and malt together with Paracasei, HEAL 9, HEAL 19, CURE 21 or Lr 271

                 Malt        +Paracasei   +HEAL 9                                    +HEAL 19                                   +CURE 21    +Lr 271                                      *P*
  -------------- ----------- ------------ ------------------------------------------ ------------------------------------------ ----------- -------------------------------------------- -------
  Caecum                                                                                                                                                                                 
   Acetic        60±5        49±3         42±3[\*\*](#TF0002){ref-type="table-fn"}   42±2[\*\*](#TF0002){ref-type="table-fn"}   55±3        44±3[\*](#TF0001){ref-type="table-fn"}       0.003
   Propionic     9±1         7±1          7±1                                        7±1                                        9±0         7±1                                          0.059
   Butyric       14±2        12±1         8±1[\*\*](#TF0002){ref-type="table-fn"}    9±1[\*](#TF0001){ref-type="table-fn"}      15±2        10±1                                         0.003
   Minor         4±0         3±0          3±0                                        3±0                                        3±0         3±0                                          0.269
   Total         86±7        71±5         60±5[\*\*](#TF0002){ref-type="table-fn"}   61±5[\*\*](#TF0002){ref-type="table-fn"}   82±5        64±4[\*](#TF0001){ref-type="table-fn"}       0.002
  Distal colon                                                                                                                                                                           
   Acetic        39±9        27±1         26±2                                       28±2                                       35±5        28±3                                         0.164
   Propionic     8±2         6±0          6±1                                        6±0                                        7±1         6±0                                          0.080
   Butyric       11±3        8±1          7±1                                        9±1                                        10±1        8±1                                          0.077
   Minor         5±2         3±1          4±1                                        4±2                                        5±2         4±1                                          0.506
   Total         64±13       44±2         42±5                                       48±4                                       58±8        45±4                                         0.118
  Portal serum                                                                                                                                                                           
   Acetic        1,095±70    897±50       837±38[\*](#TF0001){ref-type="table-fn"}   884±54                                     983±111     818±56[\*](#TF0001){ref-type="table-fn"}     0.035
   Propionic     69±10       61±6.7       45±6                                       55±9                                       77±16       48±6                                         0.103
   Butyric       103±22      88±12        55±6[\*](#TF0001){ref-type="table-fn"}     69±11                                      127±38      67±8                                         0.027
   Minor         27±3        27±2         29±3                                       31±3                                       32±5        26±1                                         0.806
   Total         1,356±103   1,139±67     1,040±49                                   1,115±63                                   1,296±117   1,024±68[\*](#TF0001){ref-type="table-fn"}   0.056

Results are given as means±SEM, *n*=6 for malt+CURE 21 and *n*=7 for all other groups. Mean values were significantly different from those for rats fed with malt:

*P*\<0.05

*P*\<0.01.

SCFAs in the portal blood {#S0003-S20004}
-------------------------

Acetic acid (820--1,090 µmol/l), propionic acid (45--77 µmol/l) and butyric acid (55--130 µmol/l) were the major SCFAs presented in portal serum ([Table 3](#T0003){ref-type="table"}). Considerable amounts of isobutyric acid (12--14 µmol/l), isovaleric acid (13--15 µmol/l) and valeric acid (4--10 µmol/l) were also detected (data not shown).

Levels of total SCFAs in the portal serum of rats were lower with malt together with HEAL 9 and Lr 271 than in rats fed only malt (*P*\<0.05), which was mainly due to the lower levels of acetic acid (*P*\<0.05). There was also a lower level of butyric acid in the portal serum of rats together with malt and HEAL 9 than with malt only (*P*\<0.05) ([Table 3](#T0003){ref-type="table"}).

Amino acids in portal plasma {#S0003-S20005}
----------------------------

The main amino acids in the portal plasma were glutamine (16%), alanine (14%), lysine (13%) and glycine (10%). Nineteen α-amino acids and ammonia were analysed in the portal blood, but only ammonia, glutamine and those showing significant differences between rats fed malt alone and malt with probiotics are shown in [Table 4](#T0004){ref-type="table"}, that is, asparagine, proline, phenylalanine and glycine. Plasma levels of glycine from rats given malt together with HEAL 9 (*P*\<0.001) or 19 (*P*\<0.05) were higher than with only malt, while the levels of asparagine (*P*\<0.05) and proline (*P*\<0.01) were higher when CURE 21 was added to the malt diet than without this strain. Lr 271 contributed to higher levels of proline (*P*\<0.05) and phenylalanine (*P*\<0.01) in the rats. None of the probiotic strains affected the glutamine levels ([Table 4](#T0004){ref-type="table"}).

###### 

Plasma levels of amino acids (µmol/l) in portal blood of rats fed malt and malt together with Paracasei, HEAL9, HEAL19, CURE2, or Lr271

                  Malt        +Paracasei   +HEAL 9                                        +HEAL 19                                   +CURE 21                                     +Lr 271                                    *P*
  --------------- ----------- ------------ ---------------------------------------------- ------------------------------------------ -------------------------------------------- ------------------------------------------ -------
  Asparagine      62±7        82±7         89±9                                           82±9                                       97±3[\*](#TF0003){ref-type="table-fn"}       69±7                                       0.001
  Proline         175±2       159±8        176±10                                         217±10                                     269±33[\*\*](#TF0004){ref-type="table-fn"}   241±24[\*](#TF0003){ref-type="table-fn"}   0.032
  Glycine         364±11      438±18       502±18[\*\*\*](#TF0005){ref-type="table-fn"}   458±28[\*](#TF0003){ref-type="table-fn"}   404±25                                       442±29                                     0.002
  Phenylalanine   54±3        62±4         74±6                                           74±5                                       65±5                                         85±9[\*](#TF0003){ref-type="table-fn"}     0.007
  Glutamine       680±26      684±28       677±29                                         633±33                                     635±28                                       638±55                                     0.739
  Ammonia         392±35      415±35       361±40                                         413±13                                     432±69                                       430±55                                     0.971
  Total           4,375±139   4,626±140    4,856±163                                      4,755±192                                  4,617±182                                    4,728±249                                  0.477

Results are given as means±SEM, *n*=6 for malt+CURE 21 and *n*=7 for all other groups. Mean values were significantly different from those for rats fed with malt:

*P*\<0.05,

*P*\<0.01,

*P*\<0.001.

Caecal microbiota {#S0003-S20006}
-----------------

The viable counts of *Lactobacillus, Bifidobacterium* and *Enterobacteriaceae* in the caecal content were not affected by any of the probiotic strains added ([Fig. 1](#F0001){ref-type="fig"}), although all the strains given to the rats, according to the supplier, survived and reached the caecum. In rats fed Paracasei, HEAL 9 or 19 or Lr 271, the given probiotic strain was also the dominant *Lactobacillus* in the caecum content ([Table 5](#T0005){ref-type="table"}). Apart from the administered probiotic strains, two other *Lactobacilli* were isolated and found in all groups, an exception was in rats fed HEAL 19 where only one of these strains was found. One of the strains belonged to species of *Lactobacillus animalis* and the other belonged to species of *Lactobacillus reuteri*. CURE 21 was not detected in the caecum of rats, which may be due to that the strain did not survive in the passage through the hindgut or to the limited culture technique.

![Viable counts of *Bifidobacterium* (white bars), *Lactobacillus* (black bars) and *Enterobacteriaceae* (grey bars) in the caecum of rats fed malt and malt together with Paracasei, HEAL9, HEAL19, CURE21 or Lr271.](FNR-58-24848-g001){#F0001}

###### 

Dominant lactobacilli and their incidence in the caecum of rats fed malt and malt with Paracasei, HEAL 9, HEAL 19, CURE 21 or Lr 271

                         Malt   +Paracasei   +HEAL 9   +HEAL 19   +CURE 21   +Lr 271
  ---------------------- ------ ------------ --------- ---------- ---------- ---------
  Probiotic strain       --     4/7          3/7       7/7        --         7/7
  *L. reuteri* strain    7/7    4/7          4/7       3/7        6/7        5/7
  *L. animalis* strain   6/7    3/7          7/7       0/7        5/7        4/7

Values are presented as incidence of specific strain per number of test rats.

Discussion {#S0004}
==========

No increase in caecal or portal levels of propionic or butyric acid were seen with any of the probiotic strains, and the results from a previous study with an increased formation of propionic and butyric acids with barley malt together with Lr 271 could not be repeated either. Instead, there was a decrease in caecal and portal levels of acetic acid when malt was given together with HEAL 9 or Lr 271, and in caecum also with HEAL 19, which might itself be beneficial, since the biosynthesis of cholesterol to a great extent is furnished by acetic acid. Furthermore, there were interesting effects on portal plasma levels of some amino acids proposed to be of metabolic impact; that is, the levels of asparagine, proline, phenylalanine or glycine were higher with all prebiotic strains (HEAL 9, 19, CURE 21, and Lr 271), except Paracasei. However, the levels of glutamine were not affected.

One may wonder why the impact of the administrated probiotics was of such little importance, but could be due to the dose of probiotics given being too low. Another reason would be that the probiotics not reached caecum, which is the actual site for fermentation. However, all probiotic strains, except Cure 21, could be found in the caecum of rats. A more likely explanation would be the physico-chemical characteristics of the fibre in this specific malt, which consisted of a high proportion of insoluble dietary fibre leading to a high unavailability in the hindgut of rats. Differences in physico-chemical properties may also explain why Lr 271 together with malt increased the levels in caecum and portal blood of rats in a previous study, and not in this study, since that specific malt was suggested to contain high amounts of fibre with low molecular weight, that is, fibres not precipitated in ethanol. Thus, if comparing the fibres in the two studies, the content of dietary fibre polysaccharides (i.e. those precipitated in 80% ethanol) of malt was considerably higher in this study (110 g/kg, dwb) than in the previous study (78 g/kg, dwb), whereas the proportion of soluble fibre was lower (8% vs. 30% in the previous study, if also taking saccharides not precipitated in 80% ethanol into account) ([@CIT0015]). The higher proportion of insoluble fibre resulted in a higher resistance to hindgut fermentation of the fibre in rats. Only 30% of the dietary fibre was degraded by the hindgut microbiota in this study, while as much as 70% was degraded in the previous study. It is also preferably oligosaccharides that are referred to as prebiotics, but in principle all fermentable fibres are potential prebiotics, which was not the case for the malt in this study. Anyway these facts show the importance of the substrate in probiotic studies, at least for effects associated to colonic fermentation and the formation of bacterial metabolites.

Decreased caecal levels of SCFAs have been seen in rats administered with probiotics in other studies, and explained by an accelerated absorption into the portal blood ([@CIT0030]). However, in this study the portal blood levels of the corresponding SCFAs in caecum were also lower together with probiotics. No difference in the degree of fermentation of the dietary fibre was observed, regardless of whether probiotics were added. This is also consistent with the fact that no differences could be seen in total viable counts of *Bifidobacterium, Lactobacillus* and *Enterobacteriaceae*, although the different strains administrated reached caecum. Again, it seems as the chemical structure of the fibre can play a major role, but the exact mechanism behind the reduced formation of SCFAs, resulting from different probiotics in combination with the malt, remains unknown. Interestingly, a change of dominant *Lactobacilli* in caecum could be seen with the strains reducing the formation of SCFAs. It may therefore be speculated, if this could be a reason. However, it cannot be excluded that this is also related to a modified composition of other bacteria in caecum, reflecting the importance to do more in-depth analyses of the microbiota composition. Another reason may be the steric effects and the architecture of the fibre that hinder enzymatic access and bacterial degradation.

None of the probiotic strains had any effects on the glutamine levels in blood. This observation included CURE 21, a probiotic bacterium that has been shown to stimulate the formation of glutamine ([@CIT0021]). No effect on caecal SCFA formation could be seen with this bacterium either. This might be due to this probiotic strain not reaching the hindgut of rats, which was also indicated during culturing of dominant *Lactobacilli*. However, all probiotic strains, except Paracasei, increased plasma portal levels of at least one of the following amino acids, asparagine, glycine, proline and phenylalanine, which is interesting per se. Glycine is an insulin secretagogue and one of the most abundant free amino acids in the blood, and therefore it is interesting that some probiotic strains (HEAL 9 and 19) were able to increase the level of glycine in blood. Albisser et al. ([@CIT0032]) showed that glycine could stimulate the excretion of insulin and the glucagon response to a higher extent in diabetic patients than in healthy controls, and Gannon et al. ([@CIT0033]) reported a dramatic reduction of the incremental glycaemic area in healthy subjects when glycine was added to a glucose drink. Another interesting amino acid in this respect is phenylalanine, known to be a potent cholecystokinin releaser and so has the capacity to slow down gastric emptying, which may be important for postprandial glucose responses and satiety after a meal ([@CIT0034]). In light of this, it is interesting that barley in some studies have been shown to affect carbohydrate metabolism ([@CIT0035]).

The increased portal level of amino acids and the absence of effects on caecal SCFA formation indicate that the probiotic strains discussed above had effects already in the small intestine and were thus acting regardless of the dietary fibre. A possible explanation of the enhancement of nutrient absorption with probiotics could be that the probiotic strains facilitate the digestion of peptides in the small intestine, and/or the transportation of amino acids and short peptides from the lumen into the intestinal epithelium. In fact, some studies have shown that probiotics mediated the absorption of nutrients. Breves et al. ([@CIT0036]) observed an increased glucose uptake rate in pre-treated pig jejunum tissue with *Saccharomyces boulardii* and *Bacillus cereus* var. toyoi, and the co-transport system for dipeptides also tended to increase. Furthermore, in a rat model, the activities of the mucosal enzymes, sucrase and maltase were increased by *S*. *boulardii* by means of releasing amines ([@CIT0037]).

Conclusions {#S0005}
===========

This study shows that the physico-chemical properties of the dietary fibre are most probably of great importance for the specific SCFAs formed, together with probiotics. In the caecum of rats, the presence of HEAL 9 or Lr 271 in the malt diet decreased the level of acetic acid, which also decreased the levels of acetic acid in the portal blood. Interestingly, a change of dominant *Lactobacilli* could be seen with these strains. Moreover, some amino acids (glycine, proline, asparagine and phenylalanine) in the portal blood of rats also increased, compared with rats fed malt only. It would be interesting to investigate the mechanism behind this increase in the future.
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